If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.09    0.015 (1.41%)
Bid:
1.07
Ask:
1.09
Spread: 0.02 (1.869%)
Market Cap: €303.89m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

Result of March 25 Tender Process (Replacement)

14 Feb 2025 17:27

RNS Number : 2497X
CVC Income & Growth Limited
14 February 2025
 

 

 

14 February 2025

 

The following amendment has been made to the announcement released on 14 February 2025 at 14:38hrs (RNS No. 2313X).

 

The Euro shares figures have been amended from 9,265 to 14,064 under the shares tendered for repurchase by the Company. The figures relating to the Euro Shares tendered for Placing have been amended from 150 to 430 and the total have been amended from 9,415 to 14,494. All other details remain unchanged. The full amended text is shown below.

 

CVC Income & Growth Limited

 

Result of March 2025 Semi-Annual Tender Process (Replacement)

 

The information contained within this announcement constitutes inside information.

 

CVC Income & Growth Limited wishes to announce that it received the following tender applications for the semi-annual tender process in respect of the March 2025 tender.

 

Share class

Shares tendered for repurchase by the Company

Shares tendered for Placing

TOTAL

Euro shares

14,064

430

14,494

Sterling shares

17,369

12

17,381

 

Shares not successfully placed pursuant to the Placing shall be deemed to have been tendered for purchase by the Company.

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Priya Mooroogen of BNP Paribas S.A., Jersey Branch, Company Secretary.

 

Enquiries:

CVC Income & Growth Limited: Robert Kirkby c/o +44 1534 815200

 

BNP Paribas S.A., Jersey Branch cvccpeolcosec@bnpparibas.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEBRGDDUDBDGUS
Date   Source Headline
18th Feb 20259:01 amRNSNet Asset Value Month End 31 Jan 2025
14th Feb 20255:27 pmRNSResult of March 25 Tender Process (Replacement)
14th Feb 20252:38 pmRNSResult of March 2025 Semi-Annual Tender Process
14th Feb 20251:50 pmRNSNet Asset Value Weekly to 07 Feb 2025
14th Feb 202510:29 amRNSIssue of Equity
13th Feb 20254:58 pmRNSIssue of Equity
11th Feb 202511:54 amRNSDirector/PDMR Shareholding
11th Feb 20259:47 amRNSHolding(s) in Company
6th Feb 20255:10 pmRNSNet Asset Value Weekly to 31 Jan 2025
6th Feb 20251:32 pmRNSIssue of Equity
5th Feb 20254:36 pmRNSIssue of Equity
5th Feb 20253:58 pmRNSDirector/PDMR Shareholding
4th Feb 20253:10 pmRNSHolding(s) in Company
4th Feb 202510:01 amRNSHolding(s) in Company
3rd Feb 20254:58 pmRNSTotal Voting Rights
31st Jan 202510:11 amRNSNet Asset Value Weekly to 24 Jan 2025
30th Jan 20255:14 pmRNSIssue of Equity
29th Jan 20253:13 pmRNSIssue of Equity
27th Jan 20256:15 pmRNSDIVIDEND DECLARATION & DIV TARGET '25(Replacement)
27th Jan 20257:00 amRNSJANUARY 2025 SHARE CONVERSION
24th Jan 20255:25 pmRNSMONTHLY REPORT
24th Jan 20252:30 pmRNSNet Asset Value Weekly to 17 Jan 2025
24th Jan 202512:53 pmRNSDividend Declaration & Annual Dividend target '25
22nd Jan 20255:08 pmRNSIssue of Equity
22nd Jan 20254:00 pmRNSIssue of Equity
21st Jan 20255:09 pmRNSNet Asset Value Month End 31 Dec 2024
17th Jan 20254:25 pmRNSNet Asset Value Weekly to 10 Jan 2025
17th Jan 20253:58 pmRNSIssue of Equity
16th Jan 20251:05 pmRNSIssue of Equity
15th Jan 20254:24 pmRNSIssue of Equity
14th Jan 20254:37 pmRNSIssue of Equity
10th Jan 20254:47 pmRNSHolding(s) in Company
10th Jan 20254:31 pmRNSIssue of Equity
9th Jan 20255:10 pmRNSNet Asset Value Weekly to 03 Jan 2025
9th Jan 20254:44 pmRNSIssue of Equity
8th Jan 20255:00 pmRNSIssue of Equity
7th Jan 20259:09 amRNSMarch 2025 Semi Annual Tender Restrictions
2nd Jan 20255:10 pmRNSNet Asset Value Weekly to 27 Dec 2024
30th Dec 20241:20 pmRNSNet Asset Value Weekly to 20 Dec 2024
20th Dec 20248:54 amRNSMonthly Report
19th Dec 20245:05 pmRNSNet Asset Value Weekly to 13 Dec 2024
18th Dec 202412:09 pmRNSNet Asset Value Month End 29 Nov 2024
17th Dec 20242:42 pmRNSJANUARY 2025 SHARE CONVERSION
12th Dec 20242:29 pmRNSNet Asset Value Weekly to 06 Dec 2024
5th Dec 202412:10 pmRNSNet Asset Value Weekly to 29 Nov 2024
2nd Dec 20249:49 amRNSTotal Voting Rights
28th Nov 20243:30 pmRNSNet Asset Value Weekly to 22 Nov 2024
22nd Nov 20244:26 pmRNSMonthly Report
22nd Nov 20244:25 pmRNSHolding(s) in Company
22nd Nov 20244:10 pmRNSMonthly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.